Phase 2 clinical trial will evaluate the safety, translational biology, and exploratory clinical efficacy of VYD2311 in people with Long COVID or COVID vaccine injuryParticipants to include people ...
Interim results indicate NS002 demonstrated significantly faster absorption and higher peak epinephrine levels compared to ...
Please provide your email address to receive an email when new articles are posted on . One in six participants in phase 2 cancer trials received a therapy that gained FDA approval. The results ...
MBX Biosciences, a clinical-stage biopharmaceutical company, has announced the completion of enrollment in its Phase 2 Avail trial for the treatment of hypoparathyroidism with canvuparatide, expecting ...
ProKidney Corp. announced positive topline results from its Phase 2 REGEN-007 trial of rilparencel in patients with chronic kidney disease (CKD) and diabetes, indicating significant improvement in ...
Maridebart cafraglutide showed up to 19.9% weight loss in obesity and 17% in obesity-diabetes patients in a phase 2 trial. The drug's 21-day half-life, combining GLP-1 receptor agonism and GIP ...
Rapport Therapeutics, Inc.'s RAP-219 delivered impressive Phase 2a results in drug-resistant focal onset seizures, driving Rapport Therapeutics' stock up over 135% and boosting investor optimism. The ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. A novel GLP-1 and amylin receptor agonist reduced HbA1c ...
INmune Bio's XPro targets neuroinflammation, showing promising biomarker results in Alzheimer's, with a potential to outperform current treatments and attract big pharma interest. The Phase 2 trial ...
Should you have feedback on this article, please complete the fields below. Please indicate if your feedback is in the form of a letter to the editor that you wish to have published. If so, please be ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results